Sri Lanka's health ministry. It runs the state hospitals where cancer care is free at the point of delivery, and its National Cancer Control Programme coordinates cancer control and the national cancer registry.
The Ministry of Health, styled the Ministry of Health and Mass Media on its website and in the 2022 national cancer registry report, runs Sri Lanka's state health system. Cancer care in that system is free at the point of delivery, as researchers who costed novel cancer drugs with Ministry procurement prices describe it, and the National Cancer Institute at Maharagama says anyone can use its services free of charge. The coordinates on this record are an approximate Colombo city point.
Cancer control sits under the Deputy Director General for Non-Communicable Diseases, through the National Cancer Control Programme (established in 1980) and the National Advisory Committee on Prevention and Control of Cancers. The Ministry's National Strategic Plan on Prevention and Control of Cancer 2020 to 2024 counted 49 board-certified clinical oncologists (44 in the public sector), radiotherapy in seven centres of excellence and 33 functional mammography units. Its Medical Statistics Unit reported 5,734 cancer deaths in government hospitals in 2022.
From April 2022 Sri Lanka's economic crisis limited imports of medicines: WHO reported that 150 essential medicines, including cancer chemotherapy drugs, were out of stock in October 2022, and in January 2023 that Sri Lanka faced a funding gap of 220 million US dollars against an annual import budget of 300 million for medicines and surgical consumables.
A worked example of how the free state system could rank costly lung cancer drugs and what price cuts would bring others within reach.
The public system held as the main source of care, but limited access to medicines and higher travel costs hurt people with long-term illness, more so in Uva than in Western province.
OnCo found no Sri Lankan national health technology assessment body for cancer drugs; this is the kind of analysis that could decide which novel drugs the free state system buys first.
Baseline data for the planned move of Sri Lanka's cervical screening programme from cytology to HPV DNA testing at age 35.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, International Agency for Research on Cancer (IARC / WHO), Cervical cancer.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares National Cancer Control Programme, Sri Lanka (NCCP), Oral cavity cancer (mouth and tongue), International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types).
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares Oral cavity cancer (mouth and tongue), International Atomic Energy Agency: Rays of Hope, Cervical cancer, Breast cancer (all types).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, Cervical cancer, Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/